Low Glycemic Index and Load Diet for the Treatment of Acne
Primary Purpose
Acne Vulgaris, Diet Modification
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Normal diet
Low glycemic diet
Adapalene 0.1% Gel
Doxycycline
Sponsored by
About this trial
This is an interventional treatment trial for Acne Vulgaris focused on measuring Acne Vulgaris, Low Glycemic Diet, Doxycycline, Adapalene
Eligibility Criteria
Inclusion Criteria:
- Having moderate inflammatory acne
- 18 to 25 years old
- Male
- Stable weight during the last 3 months
Exclusion Criteria:
- Previous or actual isotretinoin therapy
- Antibiotic therapy or during the last 3 months
- Therapy based on peelings, dermabrasion, laser or intense pulsed light during the last 6 months
- Endocrine disorders
- Drug and alcohol consumption during the last 6 months
- Tabacco use during the last 6 months
- Lactose intolerance
- Have eating disorders or gastrointestinal disorders
- Actual nutrition therapy
- Have chronic diseases that requires pharmacologic therapy
- Severe acne that requires isotretinoin therapy
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Normal Diet
Low glycemic diet
Arm Description
Participants will receive a normal diet according to their metabolic status.
Participants will receive a low-glycemic index and load diet according to their metabolic status. Milk and vitamin supplements will be eliminated from the diet.
Outcomes
Primary Outcome Measures
Count of inflammatory acne lesions
Number of papules and pustules
Secondary Outcome Measures
Count of non-inflammatory acne lesions
Number of comedones
Changes in quality of life
Score of the Dermatology Life Quality Index
Full Information
NCT ID
NCT03585140
First Posted
June 29, 2018
Last Updated
July 12, 2018
Sponsor
Centro Dermatológico Dr. Ladislao de la Pascua
1. Study Identification
Unique Protocol Identification Number
NCT03585140
Brief Title
Low Glycemic Index and Load Diet for the Treatment of Acne
Official Title
Effect of Adding a Diet With Low Glycemic Index and Load During 12 Weeks for the Treatment of Moderate Acne in Adults: a Randomized Clinical Trial
Study Type
Interventional
2. Study Status
Record Verification Date
July 2018
Overall Recruitment Status
Completed
Study Start Date
January 1, 2016 (Actual)
Primary Completion Date
May 1, 2016 (Actual)
Study Completion Date
November 30, 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Centro Dermatológico Dr. Ladislao de la Pascua
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Clinical trial to determine the effect of adding a diet with low glycemic index and load to adults for the treatment of moderate acne. Adult patients with acne where recruited in two groups, A and B. Group A received a normal diet according to their metabolic status and group B received a diet with low glycemic index and load. Outcomes were measured at week 12.
Detailed Description
Clinical trial to determine the effect of adding a diet with low glycemic index and load to adults for the treatment of moderate acne. Adult patients with acne where recruited in two groups, A and B. Both groups of treatment were treated with doxycycline 100 mg per day plus adapalene 0.1% gel daily for 12 weeks. During pharmacologic treatment, all patients had nutrition counseling monthly. Group A received a normal diet according to their metabolic status and group B received a diet with low glycemic index and load. At the end of the trial, the change in acne lesions count was analyzed and also their metabolic status. Quality of life was also measured.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acne Vulgaris, Diet Modification
Keywords
Acne Vulgaris, Low Glycemic Diet, Doxycycline, Adapalene
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized clinical trial, two-arm
Masking
InvestigatorOutcomes Assessor
Masking Description
Diet intervention was made by the nutrition specialist. Neither the principal investigator nor the outcome assessor were aware about the group of diet intervention.
Allocation
Randomized
Enrollment
52 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Normal Diet
Arm Type
Active Comparator
Arm Description
Participants will receive a normal diet according to their metabolic status.
Arm Title
Low glycemic diet
Arm Type
Experimental
Arm Description
Participants will receive a low-glycemic index and load diet according to their metabolic status. Milk and vitamin supplements will be eliminated from the diet.
Intervention Type
Other
Intervention Name(s)
Normal diet
Intervention Description
The energy consumption of each of the participants will be calculated, using the Mifflin-St Jeor formula. Each participant will receive a standard menu of 6 days according to their metabolic requirements and a list of equivalent foods. The distribution of macronutrients will be: 45% carbohydrates, 30% lipids and 25% proteins.
Intervention Type
Other
Intervention Name(s)
Low glycemic diet
Intervention Description
The energy consumption of each of the participants will be calculated, using the Mifflin-St Jeor formula. Each participant will receive a standard menu of 6 days according to their metabolic requirements and a list of equivalent foods. A list of foods classified as having low index and glycemic load was used according to the mexican equivalent food system. The distribution of macronutrients will be: 45% carbohydrates, 30% lipids and 25% proteins. Milk and vitamin supplements will be eliminated from the diet.
Intervention Type
Drug
Intervention Name(s)
Adapalene 0.1% Gel
Other Intervention Name(s)
Adapalene
Intervention Description
Adapalene 0.1% gel daily at night for 12 weeks, applied on the face, chest and back.
Intervention Type
Drug
Intervention Name(s)
Doxycycline
Intervention Description
Doxycycline 100 mg per day orally, before breakfast
Primary Outcome Measure Information:
Title
Count of inflammatory acne lesions
Description
Number of papules and pustules
Time Frame
12 weeks
Secondary Outcome Measure Information:
Title
Count of non-inflammatory acne lesions
Description
Number of comedones
Time Frame
12 weeks
Title
Changes in quality of life
Description
Score of the Dermatology Life Quality Index
Time Frame
12 weeks
10. Eligibility
Sex
Male
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
25 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Having moderate inflammatory acne
18 to 25 years old
Male
Stable weight during the last 3 months
Exclusion Criteria:
Previous or actual isotretinoin therapy
Antibiotic therapy or during the last 3 months
Therapy based on peelings, dermabrasion, laser or intense pulsed light during the last 6 months
Endocrine disorders
Drug and alcohol consumption during the last 6 months
Tabacco use during the last 6 months
Lactose intolerance
Have eating disorders or gastrointestinal disorders
Actual nutrition therapy
Have chronic diseases that requires pharmacologic therapy
Severe acne that requires isotretinoin therapy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Martha A Morales-Sánchez, MD
Organizational Affiliation
Centro Dermatológico Dr. Ladislao de la Pascua
Official's Role
Principal Investigator
12. IPD Sharing Statement
Learn more about this trial
Low Glycemic Index and Load Diet for the Treatment of Acne
We'll reach out to this number within 24 hrs